Nanophthalmics develops a patent-pending platform technology for micro fabricated instruments that engage tissue in entirely new ways.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Memphis
State: Tennessee
Zip:
Country: United States
Nanophthalmics has developed and is licensing a patent-pending platform technology for microfabricated instruments that engage tissue in entirely new ways. Their focus is on employing novel surgical devices, techniques, and materials to improve current treatment outcomes for ophthalmic and other microsurgical diseases. Their first commercial device is a disposable, 510(k) exempt, corneal micro-punch that enhances healing of abrasions, recurrent erosions, and other corneal diseases by modifying tissue attachments at a cellular level.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2012 | Seed Round | 3 | $50k |
Innova Memphis MB Venture Partners ZeroTo510 Innova Memphis MB Venture Partners ZeroTo510 |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|